Clinical Trials
6 trialsNCT01127295 2026-04-14
PHACS
Institut Claudius Regaud
Phase 4 Completed
NCT01553903 2026-04-14
OXYTAM
Institut Claudius Regaud
Phase 4 Completed
NCT01612871 2026-04-14
MIRHO
Institut Claudius Regaud
Phase 4 Completed
NCT03948568 2022-09-30
REaCT-RETT
Ottawa Hospital Research Institute
Phase 4 Completed
NCT03238703 2018-12-27
Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer
Fred Hutchinson Cancer Center
Phase 4 Withdrawn
NCT02089854 2016-12-02
AETNBC
Peking Union Medical College Hospital
Phase 4 Unknown